Technology News and Research

RSS

Alzheimer's vaccine - First evidence for efficacy

AFFiRiS' Alzheimer's vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.

12 Mar 2011

Premier endorses GHX Procurement Suite

The Premier healthcare alliance and GHX are partnering to help Premier alliance members gain better control over the purchase of medical-surgical supplies that are not in their item master or on contract, and to automate their accounts payable processes.

11 Mar 2011

Research Roundup: Mass. medical bankruptcies; Palliative care teams work; Innovative health IT

The theme for the current issue of Health Affairs Is "Profiles of Innovation in Health Care Delivery."

11 Mar 2011

Polyglot Systems, CCNC offer Meducation technology to North Carolina residents

Polyglot Systems, Inc. recently partnered with Community Care of North Carolina (CCNC), a Raleigh based health network operated by physicians, hospitals, health departments, and departments of social services, to offer Meducation® technology to support North Carolina residents who are considered low-health literate.

11 Mar 2011

NIH awards InDevR $3 million Phase II SBIR grant for influenza-related research

InDevR announced today that it has been awarded a Phase II Small Business Innovation Research grant from the National Institutes of Health in the amount of $3 million over the next 3 years.

11 Mar 2011

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.

11 Mar 2011

FDA approves Lantheus Medical Imaging's SPA for flurpiridaz F-18 Phase 3 trial in coronary artery disease

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design and planned analysis of a Phase 3 clinical trial for the assessment of myocardial perfusion using Positron Emission Tomography (PET) imaging of flurpiridaz F-18 in patients with suspected or known coronary artery disease (CAD).

11 Mar 2011

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.

11 Mar 2011

Genetic variant contributes to higher risk of lung cancer, increases tendency to smoke more

Norwegian researchers have discovered genes that increase not only one's risk of lung cancer, but perhaps one's urge to smoke as well. Now these researchers are working on developing a blood test for lung cancer.

11 Mar 2011

Researchers find four in five office-based physicians can qualify for new EHR Incentive Programs

Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.

11 Mar 2011

USAID-India fund AIP project to increase food security, agricultural production

Could you live on $1.25 per day? In parts of India-specifically the less developed states of the Indo-Gangetic Plains-living on less than $1.25 per day per capita is a harsh reality. People in this region face problems of hunger, poverty and child malnutrition.

11 Mar 2011

Simcere files IND with SFDA of China for APX003 to treat cancer

Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.

11 Mar 2011

PNP reaches several major objectives in cancer therapeutic product development

PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.

11 Mar 2011

Surgical robot acquisition increases rate of surgery to treat prostate cancer

A new study conducted by researchers at NYU Langone Medical Center and Yale School of Medicine shows that when hospitals acquire surgical robotic technology, men in that region are more likely to have prostate cancer surgery. The study, "The Association between Diffusion of the Surgical Robot and Radical Prostatectomy Rates", was published this week in the online edition of the journal Medical Care.

11 Mar 2011

OncoVista plans to advance reduced-toxicity targeted cancer treatments

OncoVista Innovative Therapies, Inc., reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more efficacious cancer treatments with reduced or no toxicity.

11 Mar 2011

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

11 Mar 2011

Sec. Clinton launches global partnership to improve maternal, child health

Secretary of State Hillary Rodham Clinton on Wednesday announced the launch of a global partnership between USAID, the Bill & Melinda Gates Foundation, the non-profit Grand Challenges Canada, the World Bank, and the government of Norway to reduce the number of deaths among mothers and infants in developing countries, the Globe and Mail reports.

11 Mar 2011

IHS opens new GE Discovery ST PET/CT system at Laurel imaging facility

Imaging Healthcare Specialists (IHS) is proud to announce the opening of a new GE Discovery ST PET/CT system at its Laurel imaging facility in Hillcrest. With the opening of this new scanner, IHS now offers state-of-art PET/CT imaging at two locations, in Hillcrest and in Encinitas.

11 Mar 2011

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

The Mount Sinai Medical Center has become the first hospital in the United States to perform a cardiac catheterization procedure using the TactiCath force-sensing ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation, or periodic rapid and irregular heartbeats.

11 Mar 2011

Technology News and Research

Alzheimer's vaccine - First evidence for efficacy

Premier endorses GHX Procurement Suite

Research Roundup: Mass. medical bankruptcies; Palliative care teams work; Innovative health IT

Polyglot Systems, CCNC offer Meducation technology to North Carolina residents

NIH awards InDevR $3 million Phase II SBIR grant for influenza-related research

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

FDA approves Lantheus Medical Imaging's SPA for flurpiridaz F-18 Phase 3 trial in coronary artery disease

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Genetic variant contributes to higher risk of lung cancer, increases tendency to smoke more

Researchers find four in five office-based physicians can qualify for new EHR Incentive Programs

USAID-India fund AIP project to increase food security, agricultural production

Simcere files IND with SFDA of China for APX003 to treat cancer

PNP reaches several major objectives in cancer therapeutic product development

Surgical robot acquisition increases rate of surgery to treat prostate cancer

OncoVista plans to advance reduced-toxicity targeted cancer treatments

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Sec. Clinton launches global partnership to improve maternal, child health

IHS opens new GE Discovery ST PET/CT system at Laurel imaging facility

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News